XML 156 R24.htm IDEA: XBRL DOCUMENT
v3.22.4

Segment Information | 12 Months Ended
--- | ---
Dec. 31, 2022
Segment Reporting [Abstract] |
Segment Information | Segment Information The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes. The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments. Approximately two-thirds of the Company’s Net sales are generated from markets outside the U.S., with approximately 45% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). Oral, Personal and Home Care sales to Walmart, Inc. and its affiliates represent approximately 11%, 12% and 12% of the Company’s Net sales in 2022, 2021 and 2020, respectively. No other customer represented more than 10% of Net sales in any period presented. In 2022, Corporate Operating profit included goodwill and intangible assets impairment charges of $721, charges resulting from the 2022 Global Productivity Initiative of $95, a gain on the sale of land in Asia Pacific of $47 and acquisition-related costs of $19. In 2021, Corporate Operating profit included goodwill and intangible assets impairment charges of $571, and a benefit of $26 related to a value-added tax matter in Brazil. In 2020, Corporate Operating profit included benefits of $16 resulting from the Global Growth and Efficiency Program and acquisition-related costs of $6.
|  | 2022 |  | 2021 |  | 2020
Net sales |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |
North America(1) |  | $ | 3,816 |  |  | $ | 3,694 |  |  | $ | 3,741 |
Latin America |  | 3,982 |  |  | 3,663 |  |  | 3,418 |
Europe |  | 2,548 |  |  | 2,841 |  |  | 2,747 |
Asia Pacific |  | 2,826 |  |  | 2,867 |  |  | 2,701 |
Africa/Eurasia |  | 1,082 |  |  | 1,045 |  |  | 981 |
Total Oral, Personal and Home Care |  | 14,254 |  |  | 14,110 |  |  | 13,588 |
Pet Nutrition(2) |  | 3,713 |  |  | 3,311 |  |  | 2,883 |
Total Net sales |  | $ | 17,967 |  |  | $ | 17,421 |  |  | $ | 16,471 |
_________ (1) Net sales in the U.S. for Oral, Personal and Home Care were $3,511, $3,391 and $3,447 in 2022, 2021 and 2020, respectively. (2) Net sales in the U.S. for Pet Nutrition were $2,432, $2,018 and $1,712 in 2022, 2021 and 2020, respectively.
|  | 2022 |  | 2021 |  | 2020
Operating profit |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |
North America |  | $ | 761 |  |  | $ | 754 |  |  | $ | 988 |
Latin America |  | 1,108 |  |  | 1,012 |  |  | 975 |
Europe |  | 514 |  |  | 682 |  |  | 652 |
Asia Pacific |  | 737 |  |  | 844 |  |  | 773 |
Africa/Eurasia |  | 228 |  |  | 203 |  |  | 206 |
Total Oral, Personal and Home Care |  | 3,348 |  |  | 3,495 |  |  | 3,594 |
Pet Nutrition |  | 850 |  |  | 901 |  |  | 793 |
Corporate |  | (1,305) |  |  | (1,064) |  |  | (502) |
Total Operating profit |  | $ | 2,893 |  |  | $ | 3,332 |  |  | $ | 3,885 |
|  | 2022 |  | 2021 |  | 2020
Capital expenditures |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |
North America |  | $ | 66 |  |  | $ | 87 |  |  | $ | 65 |
Latin America |  | 121 |  |  | 118 |  |  | 104 |
Europe |  | 31 |  |  | 44 |  |  | 41 |
Asia Pacific |  | 60 |  |  | 50 |  |  | 51 |
Africa/Eurasia |  | 30 |  |  | 33 |  |  | 13 |
Total Oral, Personal and Home Care |  | 308 |  |  | 332 |  |  | 274 |
Pet Nutrition |  | 297 |  |  | 147 |  |  | 56 |
Corporate |  | 91 |  |  | 88 |  |  | 79 |
Total Capital expenditures |  | $ | 696 |  |  | $ | 567 |  |  | $ | 409 |
|  | 2022 |  | 2021 |  | 2020
Depreciation and amortization |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |
North America |  | $ | 106 |  |  | $ | 104 |  |  | $ | 101 |
Latin America |  | 93 |  |  | 88 |  |  | 81 |
Europe |  | 90 |  |  | 98 |  |  | 94 |
Asia Pacific |  | 89 |  |  | 96 |  |  | 95 |
Africa/Eurasia |  | 9 |  |  | 9 |  |  | 9 |
Total Oral, Personal and Home Care |  | 387 |  |  | 395 |  |  | 380 |
Pet Nutrition |  | 65 |  |  | 62 |  |  | 58 |
Corporate |  | 93 |  |  | 99 |  |  | 101 |
Total Depreciation and amortization |  | $ | 545 |  |  | $ | 556 |  |  | $ | 539 |
|  | 2022 |  | 2021 |  | 2020
Identifiable assets |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |
North America |  | $ | 4,012 |  |  | $ | 4,058 |  |  | $ | 4,132 |
Latin America |  | 2,603 |  |  | 2,369 |  |  | 2,251 |
Europe |  | 3,457 |  |  | 4,432 |  |  | 5,386 |
Asia Pacific |  | 2,085 |  |  | 2,161 |  |  | 2,272 |
Africa/Eurasia |  | 694 |  |  | 599 |  |  | 605 |
Total Oral, Personal and Home Care |  | 12,851 |  |  | 13,619 |  |  | 14,646 |
Pet Nutrition |  | 2,804 |  |  | 1,342 |  |  | 1,210 |
Corporate(1) |  | 76 |  |  | 79 |  |  | 64 |
Total Identifiable assets |  | $ | 15,731 |  |  | $ | 15,040 |  |  | $ | 15,920 |
____________ (1)In 2022, Corporate identifiable assets primarily consisted of investments in equity securities (95%). In 2021, Corporate identifiable assets primarily consisted of investments in equity securities (87%) and derivative instruments (10%). In 2020, Corporate identifiable assets primarily consisted of investments in equity securities (95%).
|  | 2022 |  | 2021 |  | 2020
Long-lived assets(1) |  |  |  |  |  |
United States |  | $ | 2,569 |  |  | $ | 1,981 |  |  | $ | 1,889 |
International |  | 2,216 |  |  | 2,275 |  |  | 2,348 |
Total Long-lived assets |  | $ | 4,785 |  |  | $ | 4,256 |  |  | $ | 4,237 |
____________ (1)Long-lived assets include Property, plant and equipment, net and lease right-of-use assets.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI https://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration